GovChime
AWARDPURCHASE ORDEROther than small business

Purchase order 75N91023P00544HUMAN METABOLOME TECHNOLOGIES AMERICA, INC

Overview

Award facts

Net obligations
$16.8K
$16,800of $16.8K potential value
Outlays (paid to date)
$16.8K
$16.8K paid of $16.8K obligated$16,800
Period of performance
Jun 14, 2023 to Aug 9, 2023
Ended
Modifications
0
Latest action Jun 14, 2023
Contract type
Purchase order
PIID 75N91023P00544

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

THE METABOLOMIC ASSAYS ON PANCREATIC CANCER CELL LINES

Dates and value

Award date
Signed on Jun 14, 2023
Potential end of performance
Aug 8, 2023
Current value
$16,800Base and exercised options
Potential value (if all options are exercised)
$16,800

Obligations by fiscal year of action

  • FY2023: $16,800

Total across 1 fiscal year: $16,800

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 14, 2023. View on USAspending · Recipient on SAM.gov

Recipient

NameHUMAN METABOLOME TECHNOLOGIES AMERICA, INC
LocationBOSTON, MA
UEIVAFDJNFJ69S6
CAGE code71VC4
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyHUMAN METABOLOME TECHNOLOGIES AMERICA, INC

Business types and certifications

Self-certified small disadvantaged businessFor-profit organizationCorporation (not tax-exempt)

Self-reported at the time of the action.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NIH NCI
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NIH NCI
Funded from
National cancer institute (0849)Program activities075-0849Federal accounts (agency financial reports)

Place of performance

Place of performance
Bethesda, Montgomery County, Maryland 20892-0003
Congressional district (place of performance)
MD-08As reported at the time of the action

Classification and competition

Classification

NAICS
541714RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
Product or service (PSC)
Q301MEDICAL- LABORATORY TESTING (service)

Competition

Extent competed
Not competedC
Reason not competed
Only one source-other (FAR 6.302-1 other)ONE
Solicitation procedures
Only one sourceSSS
Set-aside
No set-aside used
Contract pricing
Firm fixed priceJ
Offers received
1

Contract details

Subcontracting plan
Plan not requiredB
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Performance-based service acquisition
No - service where PBA is not used.N

Transaction history

Modification history

Base award
Jun 14, 2023Base obligation at award: $16,800
Latest action
Jun 14, 2023 — Base awardModification 0; obligation change +$16,800
Actions by type
  • Base award1
1 actions recorded, Jun 14, 2023 to Jun 14, 2023; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
No
Simplified procedures for commercial items
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
$16,800
Latest action: change in base and all options
$16,800

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Walsh-Healey Act (materials and supplies)
No
Construction wage rates (Davis-Bacon)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Purchase orderB
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N910
Transactions recorded under this award key
1

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N910
Treasury accounts
  • 075-2023/2023-0849-000
Object classes
  • 25.6: Medical care
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression